Latest Prostate cancer Stories
‘Prostate Cancer & You’ is the first lecture in a series provided by the Urology Care Foundation, N.E.O.
First study to show that the genomic signature of prostate cancer can predict rapid development of metastatic disease in men who were managed conservatively after surgery SAN DIEGO, Dec.
The incidence of bladder cancer cases, genealogical malignancies and urinary calculi is expected to drive the U.S.
Exploratory Analysis Shows Addition of 600mg Apatorsen to Standard of Care Chemotherapy Resulted in 50 Percent Reduction in Risk of Death in Patients with Lower Performance Status Phase
ZUG, Switzerland, December 19, 2014 /PRNewswire/ -- Licence extension in the contract between AmVac and the Helmholtz Centre for the adjuvant Malp-2 offers sustainable
Cardinal Health to build 64,000 square foot, state-of-the-art facility to manufacture radioactive therapeutic agent used to treat patients with bone metastases from castration-resistant prostate cancer WHIPPANY,
MeVis Would Add Image Processing Software and Services for Detection of Cancer to Varian's Imaging Components Product Portfolio PALO ALTO, Calif., Dec.
Dr. Yang led Janssen's prostate cancer and solid tumor therapeutic area in the U.S. PLYMOUTH MEETING, Pa., Dec. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Confirmatory study will assess VolitionRx's proprietary Nucleosomics® platform for non-invasive diagnosis of lung cancer as part of larger ongoing, prospective clinical trial NAMUR, Belgium,
BOTHELL, Wash. and VANCOUVER, British Columbia, Dec. 16, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc.
- A poem in which the author retracts something said in an earlier poem.
More Images (2 images) »